Keyphrases
Withanolides
90%
Withaferin A
85%
Cisplatin
71%
Hsp90 Inhibitor
70%
Heat Shock Protein 90 (Hsp90)
68%
Adrenocortical Carcinoma
61%
Antiproliferative Activity
55%
Induced Apoptosis
55%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
49%
Melanoma
48%
Tumor
39%
Primary Hyperparathyroidism (pHPT)
39%
Hyaluronan
38%
Lymphatics
38%
Physalis Longifolia
33%
Heat Shock Protein 90 Inhibitor
33%
Synthetic High-density Lipoprotein
30%
Metastatic Melanoma
30%
Thyroid Cancer
29%
Nanoconjugates
28%
In Cancer
28%
Cytotoxicity
27%
Medullary Thyroid Carcinoma
26%
Parathyroidectomy
25%
Triacetate
24%
Novobiocin
24%
Intralymphatic
24%
Heat Shock Response
23%
Lymphatic System
22%
Nanoparticles
22%
Combination Therapy
22%
Anticancer Activity
21%
Mitogen-activated Protein Kinase
20%
Chemotherapy
20%
Malignancy
19%
Entrepreneurship
18%
Overall Survival
18%
Parathyroid Hormone Levels
18%
Apoptosis
17%
Head-and-neck
17%
Phosphorylation
17%
Terminal Heat
17%
Physalis
17%
Cancer Cell Lines
17%
Long Non-coding RNA (LncRNA)
16%
Novel Therapeutics
16%
Western Blot Analysis
16%
Dose Effect
16%
Self-renewal
16%
PI3K-AKT-mTOR Pathway
16%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Withanolide
84%
Withaferin A
77%
Cisplatin
71%
Thyroid Cancer
59%
Adrenal Cortex Carcinoma
53%
Heat Shock Protein 90 Inhibitor
51%
Head and Neck Squamous Cell Carcinoma
49%
Breast Cancer
47%
Neoplasm
46%
Melanoma
46%
Disease
45%
Hyaluronic Acid
40%
Physalis
35%
Chemotherapy
34%
Antiproliferative Activity
34%
IC50
32%
High Density Lipoprotein
30%
Cytotoxicity
28%
Western Blot
24%
Structure Activity Relationship
23%
Combination Therapy
22%
Squamous Cell Carcinoma
22%
Nanoparticle
21%
Mouse
20%
Nanocarrier
19%
Thyroid Medullary Carcinoma
19%
Doxorubicin
19%
Heat Shock Protein 90
19%
Triple Negative Breast Cancer
18%
Carboxamide
17%
Nanoconjugate
17%
Glioblastoma
17%
Clinical Trial
16%
Natural Product
16%
Sorafenib
15%
Novobiocin
15%
Deferoxamine
15%
Mitogen Activated Protein Kinase Kinase Inhibitor
15%
Metastatic Melanoma
15%
Parathyroid Hormone
15%
Neuroblastoma
15%
Lactone
14%
Tanespimycin
14%
Chaperone
14%
Phosphotransferase
13%
Protein Tyrosine Kinase
13%
Differentiated Thyroid Cancer
12%
Cell Viability
12%
Anticarcinogen
12%
Medicine and Dentistry
Nodular Melanoma
73%
Disease
48%
Withanolide
40%
Thyroid Cancer
39%
Primary Hyperparathyroidism
39%
Parathyroidectomy
39%
Parathyroid Hormone
35%
Lymph Duct
34%
In Vitro
32%
Surgeon
31%
Adrenal Cortex Carcinoma
30%
Metastatic Carcinoma
29%
Malignant Neoplasm
28%
Cancer
27%
Surgery
27%
Head and Neck Squamous Cell Carcinoma
26%
Withaferin A
25%
Restylane
24%
Neoplasm
24%
Cisplatin
23%
Hsp90 Inhibitor
23%
Programmed Cell Death
23%
Recurrent Disease
20%
Thyroidectomy
20%
Cancer Cell
20%
Metastatic Melanoma
20%
Cancer Stem Cell
19%
Thyroid Medullary Carcinoma
19%
Lymphatic System
18%
Positron Emission Tomography
18%
Carboxy Terminal Sequence
18%
Neck
18%
Isotopes of Calcium
17%
Fine-Needle Aspiration
17%
Conjugate
16%
Hormone Determination
16%
Targeted Therapy
16%
Breast Cancer
15%
Sentinel Lymph Node Biopsy
15%
Breast Reconstruction
15%
Parathyroid
15%
Thyroid Nodule
15%
Deferoxamine
15%
IC50
14%
Overall Survival
14%
General Surgery
13%
Patient Care
13%
Fluorodeoxyglucose
13%
Tumor Cell
12%
Fluorodeoxyglucose F 18
12%